More News – Page 238
-
NewsNew pasteurization method wipes out pathogens on buckwheat sprouting seeds, study shows
A new pasteurization technique uses plasma, vacuum packaging and hot water to inactivate food pathogens on buckwheat seeds, cutting the risk of food poisoning outbreaks without preventing the seeds from sprouting. The technique, which reduces the total time for seed pasteurization,was developed by scientists at Kyonggi University ...
-
NewsRisk of death reduces after COVID-19 vaccine but protection wanes after six months
The risk of death from COVID-19 decreases significantly after vaccination but this protection diminishes after six months, providing evidence for continued booster doses, a new study has found.
-
NewsDiverse gut bacteria communities protect against harmful pathogens by nutrient blocking
A new study demonstrates that diverse communities of resident bacteria can protect the human gut from disease-causing microorganisms. However, this protective effect is lost when only single species of gut bacteria are present.
-
NewsAncient DNA reveals how a chicken virus evolved to become more deadly
Scientists have used ancient DNA to trace the evolution of Marek’s Disease Virus (MDV), showing how viruses evolve to become more virulent and could lead to the development of better ways to treat viral infections.
-
NewsNew understanding of ancient genetic parasite may spur medical breakthroughs
Scientists have published the first high-resolution images and structural details of a virus-like element known as LINE-1, describing it as “an ancient genetic parasite” that is one of the most common parts of human DNA.
-
NewsCockroaches can transmit antimicrobial resistance genes between groups
A new paper describes a study of antimicrobial resistance (AMR) transmission among cockroaches, with implications for AMR transmission in humans.
-
NewsBreastfeeding alters infant gut in ways that boost brain development, may improve test scores
A study of the infant ‘fecal metabolome’ suggests that nursing, including part-time while supplementing with formula, yields significant brain-health benefits.
-
NewsGut bacteria of malnourished children benefit from key elements in therapeutic food
Researchers investigating a new therapeutic food aimed at repairing malnourished children’s underdeveloped gut microbiomes has identified key, naturally occurring biochemical components and the important bacterial strains that process these components.
-
News3G microbial cell factories: achieving sustainable goals with engineered microorganisms
Scientists review the progress made in the development of artificial biological systems for 3G refineries over the last decade.
-
NewsScientists reveal rare enzyme role change with bacterial defense system assembly
A never-before-seen phenomenon in a protein: alone, the enzyme processes DNA and RNA but, when bound to another protein as part of a defense system, interacts with a completely different type of compound to help bacteria commit suicide.
-
NewsMaking probiotics more widely applicable through ‘CRISPR’ engineering
Scientists review the recent progress and challenges in the production and use of genetically modified probiotics.
-
NewsInfection with stomach bacteria may increase risk of Alzheimer’s disease
Infection with the stomach bacterium Helicobacter pylori could increase the risk of developing Alzheimer’s disease. In people over the age of 50, the risk following a symptomatic infection can be an average of 11 per cent higher.
-
NewsDr Thomas Thompson named as winner of inaugural John Snow Prize
Dr Thomas Thompson of Queen’s University Belfast in Northern Ireland has been named as this year’s winner of the inaugural John Snow Prize for microbiology. The prize is part of the Applied Microbiology International Horizon Awards, which celebrate the brightest minds in the field and promote the ...
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
News Researchers develop a novel dry-powder inhaled vaccine platform
Researchers have developed a single-dose, dry-powder, inhalable vaccine platform using nano-micro composite multilevel structures, which is effective in blocking respiratory viral infection and transmission in animal models.
-
NewsCall for papers for themed Pseudomonas collection in Letters in Applied Microbiology
The journal Letters in Applied Microbiology is to run a themed collection on ’Emerging Horizons in Pseudomonas Biotechnology – Innovations from Early-Career Researchers’.
-
News‘Long flu’ has emerged as a consequence similar to long COVID
A new study shows patients hospitalized for flu or COVID-19 face an increased risk of long-term health problems and death.
-
NewsNovel early-detection method aims to stem disease spread in animal trade
Researchers have described a simplified method to detect a deadly fungus killing European salamanders - Batrachochytrium salamandrivorans, or Bsal.
-
NewsBlack individuals more likely to experience inequities in early diagnosis of Lyme disease
A new study reveals that black patients are more likely to have advanced stages of Lyme disease when clinically diagnosed and also experience a longer time before receiving antibiotic treatment for the condition.